FactaeThe Factual News

Ultragenyx: Drug for rare disease fails in late-stage trial

Ultragenyx reports failure of a late-stage clinical trial.

Published 3h1 sourceupdated 2h
Lire en français
≈ 13s

The fact

The drug targeted a rare genetic disease.

This setback may affect the biotech company's valuation.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
États-UnisWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on September 2, 2026
← Back to home
Discover

Read more

All marches →
marches

Taiwan: Companies plan $20 billion in investments in the United States

20h · 1 sourcemarches

Iran threatens the United States following deadly airstrikes

8h · 1 sourcemarches

Drone attack on Kyiv: five injured and material damage

9h · 1 sourcemarches

Germany faces rising borrowing rates and global financial instability

14h · 1 sourcemarches

Russian minister attends G20 Finance plenary session

15h · 1 sourcemarches

Elliott fund opposes Deutsche Telekom and T-Mobile merger

5h · 1 source